Exercise and Vascular Function in Chronic Kidney Disease
Exercise and Vascular Function in Chronic Kidney Disease
批准号:
8862523
负责人:
DAVID G EDWARDS
金额:
$38.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-15 至 2017-06-30
关键词:
3-nitrotyrosineAdhesionsAdultAerobic ExerciseAffectArteriesAscorbic AcidAtherosclerosisBlood VesselsCardiovascular DiseasesCardiovascular systemCell ProliferationChronic Kidney FailureClinicalClinical Practice GuidelineCounselingCutaneousDataDevelopmentDialysis patientsDialysis procedureEducational InterventionEffectivenessElderlyEndothelial CellsEnzymesEventExerciseForearmFoundationsGoalsHealthHeatingHemodialysisInfusion proceduresInterventionInvestigationKidneyKidney DiseasesKidney FailureLaser-Doppler FlowmetryLeukocytesLow Density Lipoprotein oxidationMeasuresMediatingMicrodialysisMolecularMorbidity - disease rateNADPH OxidaseNG-Nitroarginine Methyl EsterNitric OxideOutcomeOxidantsOxidative StressPathologicPatientsPharmaceutical PreparationsPhysical activityPlatelet Aggregation InhibitionPrevalenceProductionPublic HealthRandomizedReactive Oxygen SpeciesRecommendationRenal functionRiskRisk FactorsRoleSecondary toSiteSmooth Muscle MyocytesTestingTherapeuticTrainingUnited StatesVascular Endothelial CellVasodilationantioxidant enzymebasebrachial arterycardiovascular disorder riskcardiovascular risk factorcell injuryendothelial dysfunctionimprovedindexingmortalityoxidative damagereactive hyperemiaresponsetherapy designtrial designvolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chronic kidney disease (CKD) is a major Public Health problem affecting more than 20 million adults in the United States. In addition to the risk of progressing to renal failure, CKD is associated with an increased prevalence of cardiovascular disease (CVD) that is not fully explained by traditional risk factors. Impaired endothelial function is a primary event in the development of atherosclerosis and CVD and its complications are the most important cause of morbidity and mortality in CKD. Oxidative stress is elevated in patients with CKD and those on hemodialysis and appears to impair endothelial function. Thus, endothelial dysfunction secondary to oxidative stress may cause renal function to deteriorate and CVD risk to increase in CKD. Interventions designed to restore vascular function in CKD are required to improve renal and cardiovascular outcomes in these patients. Aerobic exercise training has been shown to reduce oxidative stress and improve vascular function and may be an effective adjunct therapeutic strategy in CKD however its use in CKD has yet to be investigated. We propose to investigate the effects of aerobic exercise training on microvascular and conduit artery endothelial function in CKD. We specifically hypothesize that exercise training will improve nitric oxide mediated cutaneous vasodilation and brachial artery endothelial-dependent dilation. We also hypothesize that oxidative stress will be reduced, and that cutaneous vasodilation will be unaffected by local ascorbic acid infusion following exercise training. Endothelial cells will be obtained to assess the effects of exercise training on vascular
endothelial cell oxidative stress and related molecular mechanisms. CKD patients will randomized to either 12 weeks of aerobic exercise training or control period. Flow mediated dilation of the brachial artery will be used to assess conduit endothelial-dependent dilation and cutaneous vasodilation in response to local heating using laser Doppler flowmetry and intradermal microdialysis will be assessed in the forearm to evaluate the microvasculature. Cutaneous vasodilation in response to local heating will be assessed at a Ringers (control) site, L-NAME site (to assess the NO contribution), and an ascorbic acid site (to assess the role of oxidative stress). These measures will be at baseline and 12 weeks. This comprehensive endothelial assessment in will allow us to definitively determine if exercise training improves vascular health in patients with CKD.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.niox.2020.10.002
发表时间:
2021-01-01
期刊:
Nitric oxide : biology and chemistry
影响因子:
--
作者:
[Ramick MG, Kirkman DL, Stock JM, Muth BJ, Farquhar WB, Chirinos JA, Doulias PT, Ischiropoulos H, Edwards DG]
通讯作者:
Edwards DG
DOI:
10.1053/j.jrn.2014.07.012
发表时间:
2014
期刊:
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
影响因子:
--
作者:
[Kirkman,DanielleL, Lennon-Edwards,Shannon, Edwards,DavidG]
通讯作者:
Edwards,DavidG
Exercise as an Adjunct Therapy In Chronic Kidney Disease.
运动作为慢性肾脏病的辅助疗法。
DOI:
--
发表时间:
2014
期刊:
Renal nutrition forum
影响因子:
--
作者:
[Kirkman,DanielleL, Edwards,DavidG, Lennon-Edwards,Shannon]
通讯作者:
Lennon-Edwards,Shannon
Center of Biomedical Research Excellence in Cardiovascular Health
-
批准号:9883011
-
项目类别:
-
资助金额:$234.0万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Center of Biomedical Research Excellence in Cardiovascular Health Administrative Core
-
批准号:10640262
-
项目类别:
-
资助金额:$60.93万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Center of Biomedical Research Excellence in Cardiovascular Health Administrative Core
-
批准号:10271698
-
项目类别:
-
资助金额:$44.53万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Center of Biomedical Research Excellence in Cardiovascular Health
-
批准号:10640261
-
项目类别:
-
资助金额:$231.34万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Center of Biomedical Research Excellence in Cardiovascular Health
-
批准号:10271697
-
项目类别:
-
资助金额:$229.67万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Center of Biomedical Research Excellence in Cardiovascular Health
-
批准号:10475082
-
项目类别:
-
资助金额:$234.73万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Center of Biomedical Research Excellence in Cardiovascular Health Administrative Core
-
批准号:10475083
-
项目类别:
-
资助金额:$60.93万
-
财政年份:2016
-
负责人:DAVID G EDWARDS
-
依托单位:
Exercise and Vascular Function in Chronic Kidney Disease
-
批准号:8699826
-
项目类别:
-
资助金额:$39.22万
-
财政年份:2013
-
负责人:DAVID G EDWARDS
-
依托单位:
Exercise and Vascular Function in Chronic Kidney Disease
-
批准号:8437917
-
项目类别:
-
资助金额:$41.24万
-
财政年份:2013
-
负责人:DAVID G EDWARDS
-
依托单位:
Vascular effects of dietary salt in humans with salt-resistant BP
-
批准号:8186146
-
项目类别:
-
资助金额:$39.74万
-
财政年份:2011
-
负责人:DAVID G EDWARDS
-
依托单位:
Vascular effects of dietary salt in humans with salt-resistant BP
-
批准号:8329607
-
项目类别:
-
资助金额:$38.42万
-
财政年份:2011
-
负责人:DAVID G EDWARDS
-
依托单位:
Vascular effects of dietary salt in humans with salt-resistant BP
-
批准号:8698453
-
项目类别:
-
资助金额:$37.06万
-
财政年份:2011
-
负责人:DAVID G EDWARDS
-
依托单位:
VASCULAR EFFECTS OF DIETARY SALT IN HUMANS WITH SALT-RESISTANT BP
-
批准号:9981485
-
项目类别:
-
资助金额:$59.27万
-
财政年份:2011
-
负责人:DAVID G EDWARDS
-
依托单位:
Vascular effects of dietary salt in humans with salt-resistant BP
-
批准号:8507269
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2011
-
负责人:DAVID G EDWARDS
-
依托单位:
VASCULAR EFFECTS OF DIETARY SALT IN HUMANS WITH SALT-RESISTANT BP
-
批准号:10214661
-
项目类别:
-
资助金额:$59.27万
-
财政年份:2011
-
负责人:DAVID G EDWARDS
-
依托单位:
Microvascular Function in Chronic Kidney Disease
-
批准号:7364266
-
项目类别:
-
资助金额:$21.63万
-
财政年份:2008
-
负责人:DAVID G EDWARDS
-
依托单位:
Oxidative Stress and Vascular Function in Chronic Kidney Disease
-
批准号:7313224
-
项目类别:
-
资助金额:$23.24万
-
财政年份:2007
-
负责人:DAVID G EDWARDS
-
依托单位:
Oxidative Stress and Vascular Function in Chronic Kidney Disease
-
批准号:7476485
-
项目类别:
-
资助金额:$17.92万
-
财政年份:2007
-
负责人:DAVID G EDWARDS
-
依托单位:
COBRE in CV Health Research Core
-
批准号:9883020
-
项目类别:
-
资助金额:$24.58万
-
财政年份:--
-
负责人:DAVID G EDWARDS
-
依托单位:
COBRE in CV Health Administrative Core
-
批准号:9883019
-
项目类别:
-
资助金额:$147.07万
-
财政年份:--
-
负责人:DAVID G EDWARDS
-
依托单位:
海外基金